Is ITCI stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Intra-Cellular Therapies 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $14.72, you would have made a profit of $58.77 per share or 399.25%
Yes, the average daily trading liquidity for Intra-Cellular Therapies is $78.70 million. You should therefore be able to get in and out of your positions relatively fast.
Intra-Cellular Therapies has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Intra-Cellular Therapies to be medium [0.7 out of 1]